Koers InVitro International Other OTC
Aandelen
IVRO
US4618531036
Farmaceutische producten
Omzet 2022 | 854K 787K | Omzet 2023 | 793K 731K | Marktkapitalisatie | 1,3 mln. 1,2 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 | Nettowinst (verlies) 2023 | - 0 | EV/omzet 2022 | 0,29 x |
Nettoliquiditeiten 2022 | 1,23 mln. 1,14 mln. | Nettoliquiditeiten 2023 | 1,13 mln. 1,04 mln. | EV/omzet 2023 | 0,22 x |
K/w-verhouding 2022 |
69,3
x | K/w-verhouding 2023 |
885
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 96,73% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
W. Ulmer
CEO | Chief Executive Officer | - | 15-09-19 |
Cathy Richmond
DFI | Director of Finance/CFO | - | 15-09-19 |
Atul Jhalani
PSD | President | - | 03-06-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Irwin Gruverman
BRD | Director/Board Member | 89 | 23-09-20 |
Dennis Chenoweth
BRD | Director/Board Member | - | - |
W. Ulmer
CEO | Chief Executive Officer | - | 15-09-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,59% | 727 mld. | |
-7,89% | 354 mld. | |
+15,66% | 328 mld. | |
+0,24% | 277 mld. | |
+13,47% | 243 mld. | |
+7,35% | 205 mld. | |
-6,42% | 203 mld. | |
+4,23% | 164 mld. | |
-1,70% | 164 mld. |